08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
07/19/2024
8:22 AM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/25/2024
7:30 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:16 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/24/2024
6:06 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:23 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:25 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:35 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:15 PM | Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:19 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Gallagher Brian M. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:36 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:51 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/09/2024
3:06 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:08 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
5:05 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form DEF 14A | |
04/26/2024
5:10 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form DEFA14A | |
04/26/2024
5:14 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form ARS | |
04/16/2024
7:00 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form PRE 14A | |
04/04/2024
7:38 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:40 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
04/04/2024
7:15 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B5 | |
04/02/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
03/29/2024
1:51 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form POS AM | |
03/28/2024
3:02 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024
7:57 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:10 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:39 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:20 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:22 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:25 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:27 PM | Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:48 PM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:48 AM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:14 PM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
01/30/2024
7:31 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
7:01 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Could TSLA reach $500 a share? Free ebook says it’s possible. (Ad) Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner.
In his professional opinion, the share price could reach $500 or more…
Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound.
In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now…
For the time being, he’s giving away his Tesla ebook for free.
Inside explains how shares could reach $500 in the near future. To claim your copy, follow this link |
01/10/2024
7:06 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
01/08/2024
7:19 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
01/08/2024
7:15 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:23 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:23 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:31 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
12/08/2023
7:31 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/29/2023
4:07 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
George Simeon (Reporting)
SR One Capital Fund I Aggregator LP (Reporting)
SR ONE CAPITAL MANAGEMENT, LLC (Reporting)
SR ONE CAPITAL PARTNERS I, LP (Reporting)
SR One Co-Invest I Manager, LLC (Reporting)
SR One Co-Invest I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
7:15 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
7:18 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/22/2023
3:16 PM | COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
11/16/2023
4:30 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:26 PM | Byrnes Michael (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
3:33 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/13/2023
3:23 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:25 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
